Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer

BACKGROUND: Solute Carrier Family 6 Member 1 (SLC6A1) has been identified as a cancer-promoting gene in various human cancers, such as clear cell renal cell carcinoma and ovarian cancer. However, its roles in prostate cancer (PCa) has not been fully elucidated. The aim of this study was to investiga...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Chen, Chaojiang, Cai, Zhiduan, Zhuo, Yangjia, Xi, Ming, Lin, Zhuoyuan, Jiang, Funeng, Liu, Zezhen, Wan, Yueping, Zheng, Yu, Li, Jianxin, Zhou, Xing, Zhu, Jianguo, Zhong, Weide
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7137497/
https://ncbi.nlm.nih.gov/pubmed/32252682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-06776-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi